Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cardiff Oncology (CRDF) Interest Expenses (2017 - 2018)

Cardiff Oncology's Interest Expenses history spans 8 years, with the latest figure at $232.0 for Q4 2018.

  • For Q4 2018, Interest Expenses changed N/A year-over-year to $232.0; the TTM value through Sep 2019 reached $232.0, down 99.08%, while the annual FY2020 figure was $2000.0, N/A changed from the prior year.
  • Interest Expenses for Q4 2018 was $232.0 at Cardiff Oncology, up from $16.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $541273.0 in Q4 2016 and bottomed at $16.0 in Q3 2018.
  • The 5-year median for Interest Expenses is $45918.5 (2014), against an average of $182579.5.
  • The largest annual shift saw Interest Expenses soared 8090.72% in 2014 before it crashed 99.96% in 2018.
  • A 5-year view of Interest Expenses shows it stood at $389871.0 in 2014, then dropped by 9.53% to $352727.0 in 2015, then skyrocketed by 53.45% to $541273.0 in 2016, then tumbled by 93.14% to $37123.0 in 2017, then tumbled by 99.38% to $232.0 in 2018.
  • Per Business Quant, the three most recent readings for CRDF's Interest Expenses are $232.0 (Q4 2018), $16.0 (Q3 2018), and $925.0 (Q2 2018).